Revolutionizing first-line cervical cancer treatment: bevacizumab, immunotherapy, and emerging insights. Lima WAL, Gouveia MC, Oliveira LCM, Scaranti M, et al. Int J Gynecol Cancer 2025 Jan 28:101661. doi: 10.1016/j.ijgc.2025.101661.

Read + Share

Amedeo Smart

Independent Medical Education

Lima WAL, Gouveia MC, Oliveira LCM, Scaranti M, et al. Revolutionizing first-line cervical cancer treatment: bevacizumab, immunotherapy, and emerging insights. Int J Gynecol Cancer 2025 Jan 28:101661. doi: 10.1016/j.ijgc.2025.101661.
PMID: 40175267